Tumor evolution and drug response in pancreatic cancer organoids by means of EUS-guided fine-needle aspiration

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028000

Enrollment

Unknown

Registered

2019-12-08

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

Case series:EUS-FNA

Eligibility

Sex/Gender

Male

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with pancreatic cancer or suspected pancreatic cancer aged over 18 and under 80

Exclusion criteria

Exclusion criteria: Pancreatic cancer pantients with severe coagulation system disease; with severe cardiopulmonary dysfunction, which can not tolerate endoscopic ultrasonography

Design outcomes

Primary

Measure	Time frame
Tissue from EUS-FNA;	—

Countries

China

Contacts

Public ContactYang Fan

Shengjing Hospital of China Medical University

yangf1@sj-hospital.org+86 18940254653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026